Insider trades

Ted Monohon, CAO of Quince Therapeutics QNCX, has filed 0 purchases and 1 sale on the open market. The latest trade was on 23/03/06.

Ted Monohon

Chief Accounting Officer & VP
First filing
23/02/02
Trades
2 trades
Buys / sales
0 / 1
12-month net buying
No record
Last trade
23/03/06

Trading activity

Transactions

Trade type
Open-market sale23/03/0623/03/061,871 sh$0.98$1,833.58−6.4%